Clinical Trials Logo

Opioid-induced Constipation clinical trials

View clinical trials related to Opioid-induced Constipation.

Filter by:

NCT ID: NCT01040637 Completed - Healthy Clinical Trials

A Multiple Dose Study of TD-1211 in Healthy Volunteers and Patients With Opioid-Induced Constipation

Start date: January 2010
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to evaluate the safety, tolerability and pharmacokinetics of TD-1211 in healthy subjects and activity in subjects with opioid-induced constipation (OIC).

NCT ID: NCT00984334 Completed - Chronic Pain Clinical Trials

Naloxone SR Capsules in Patients With Opioid Induced Constipation

Start date: October 2009
Phase: Phase 2
Study type: Interventional

For many patients taking opioids for pain relief one of the most distressing side effects is constipation. Naloxone is effective in the reversal of the effects of opioids and is used following opioid overdose. If naloxone is given by mouth it would relieve the effects of constipation but as it goes into the blood stream very quickly, it would also reverse the effects of the opioid and therefore stop the pain relief. The aim of this study is to examine a slow release formulation of naloxone to see if is can reduce constipation without reducing the pain relieving effects of the opioid.

NCT ID: NCT00672477 Completed - Clinical trials for Opioid-Induced Constipation

Study Evaluating Subcutaneous Methylnaltrexone For Treatment Of Opioid-Induced Constipation In Patients With Advanced Illness

Start date: June 2008
Phase: Phase 4
Study type: Interventional

This study will evaluate the safety and efficacy of methylnaltrexone administered as subcutaneous injections in subjects who have opioid-induced constipation and an advanced illness. The hypothesis is that methylnaltrexone will be safe and effective in relieving opioid-induced constipation in these subjects.

NCT ID: NCT00672139 Completed - Clinical trials for Opioid-Induced Constipation

Safety of Subcutaneous Methylnaltrexone for Opioid-Induced Constipation in Patients With Advanced Illness

Start date: July 2008
Phase: Phase 4
Study type: Interventional

This is an open-label, multicenter extension of study 3200K1-4000-WW that will evaluate the safety of methylnaltrexone. This drug will be administered by subcutaneous injection and will be tested in late stage, advanced illness patients who have constipation caused by opioid pain relievers. This study will last 3 months.

NCT ID: NCT00640146 Completed - Clinical trials for Opioid-induced Constipation

Study of Subcutaneous Methylnaltrexone (MNTX) in the Treatment of Opioid-Induced Constipation During Rehabilitation After Orthopedic Procedures

Start date: October 19, 2007
Phase: Phase 2
Study type: Interventional

The purpose of this study is to examine the safety and activity of MNTX in relieving opioid-induced constipation following orthopedic procedures.